All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
PRECeDe Trial: Prevention of neonatal Respiratory distress with antenatal corticosteroids prior to Elective Caesarean section in women with diabetes – A Randomised Trial
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
PUERTA: A novel treatment for patients in acute respiratory distress
ALT-100-002: Pioneering the Utility of eNAMPT-Reducing Therapies in Acute Respiratory Distress Syndrome [ARDS]/ ventilator-induced lung injury.
Evaluating a new treatment for paediatric patients with ulcerative colitis.
The purpose of this study is to evaluate the effectiveness of guselkumab in pediatric participants with moderately to severely active ulcerative colitis through open label induction and through maintenance therapy among participants who were induction responders.
Do you have Muscle-invasive Bladder Cancer?
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.
Healing and Disease-Modifying Effect of Guselkumab in Crohn’s Disease Patients
A disease modification drug for Temporal Lobe Epilepsy
A disease modification drug for Temporal Lobe Epilepsy
SNDX-6352-0506 - Axatilimab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Axatilimab is a “monoclonal antibody”, which is an antibody manufactured in a laboratory. It is designed to specifically block a protein believed to be involved in lung fibrosis. By blocking this protein, Axatilimab may slow or stop the progression of IPF.
Testing a new treatment for people with Crohn's Disease
A Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)